Diethyl Ether → 10-[4-((3r)-3-Hydroxy-2-methyl-cyclohex-1-en-1-yl)-3-methyl-benzoyl]-10,11-dihydro-5h-pyrrolo[2,1-c][1,4]benzodiazepine-3-carboxylic acid methyl-pyridin-3-yl methyl-amide l-(+)-tartaric acid salt
Reaction equation
[CH3:1][CH2:2][N:3]([C:37]1[CH:38]=[N:39][CH:40]=[CH:41][CH:42]=1)[C:4]([C:6]1[N:15]2[C:9]([CH2:10][N:11]([C:20](=[O:36])[C:21]3[CH:26]=[CH:25][C:24]([C:27]4[CH2:32][CH2:31][CH2:30][C@@H:29]([OH:33])[C:28]=4[CH3:34])=[C:23]([CH3:35])[CH:22]=3)[C:12]3[CH:19]=[CH:18][CH:17]=[CH:16][C:13]=3[CH2:14]2)=[CH:8][CH:7]=1)=[O:5].C(OCC)C.[C:48]([OH:57])(=[O:56])[C@@H:49]([C@H:51]([C:53]([OH:55])=[O:54])[OH:52])[OH:50]>CO>[C:48]([OH:57])(=[O:56])[C@@H:49]([C@H:51]([C:53]([OH:55])=[O:54])[OH:52])[OH:50].[CH3:1][CH2:2][N:3]([C:37]1[CH:38]=[N:39][CH:40]=[CH:41][CH:42]=1)[C:4]([C:6]1[N:15]2[C:9]([CH2:10][N:11]([C:20](=[O:36])[C:21]3[CH:26]=[CH:25][C:24]([C:27]4[CH2:32][CH2:31][CH2:30][C@@H:29]([OH:33])[C:28]=4[CH3:34])=[C:23]([CH3:35])[CH:22]=3)[C:12]3[CH:19]=[CH:18][CH:17]=[CH:16][C:13]=3[CH2:14]2)=[CH:8][CH:7]=1)=[O:5]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
10-[4-((3R)-3-Hydroxy-2-methyl-cyclohex-1-en-1-yl)-3-methyl-benzoyl]-10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-3-carboxylic acid methyl-pyridin-3-yl methyl-amide (0.120 g, 0.214 mmol) of Example 3, was dissolved in boiling diethyl ether. A solution of L-(+)-tartaric acid (0.0320 g, 0.214 mmol) in hot methanol (1 mL) was added, the mixture cooled and solvent evaporated. Diethyl ether was added to the residue causing a white solid to form which was filtered and dried in vacuo to afford 0.152 g of the title compound as the tartaric acid salt.
Workup
- temperaturethe mixture cooled
- customsolvent evaporated
- additionDiethyl ether was added to the residue
- customto form which
- filtrationwas filtered
- customdried in vacuo
Sources & evidence
- ORD record
- ord-719cb718b1e74f00a136f28443a2bb61
- Source dataset
- uspto-grants-2005_06
- Patent number
- US06903087B2
Reaction notes
Loading…